JPH04134091A - Production of trehalose isomer - Google Patents
Production of trehalose isomerInfo
- Publication number
- JPH04134091A JPH04134091A JP25194690A JP25194690A JPH04134091A JP H04134091 A JPH04134091 A JP H04134091A JP 25194690 A JP25194690 A JP 25194690A JP 25194690 A JP25194690 A JP 25194690A JP H04134091 A JPH04134091 A JP H04134091A
- Authority
- JP
- Japan
- Prior art keywords
- formula
- compound
- formulas
- acetyl group
- tables
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000004519 manufacturing process Methods 0.000 title claims description 7
- 150000003625 trehaloses Chemical class 0.000 title claims 3
- 150000001875 compounds Chemical class 0.000 claims abstract description 55
- HDTRYLNUVZCQOY-BTLHAWITSA-N alpha,beta-trehalose Chemical class O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-BTLHAWITSA-N 0.000 claims abstract description 13
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 claims abstract description 11
- 230000008707 rearrangement Effects 0.000 claims abstract description 7
- 230000006196 deacetylation Effects 0.000 claims abstract description 5
- 238000003381 deacetylation reaction Methods 0.000 claims abstract description 5
- 238000000034 method Methods 0.000 claims description 16
- 239000000126 substance Substances 0.000 claims description 16
- MEKOFIRRDATTAG-UHFFFAOYSA-N 2,2,5,8-tetramethyl-3,4-dihydrochromen-6-ol Chemical compound C1CC(C)(C)OC2=C1C(C)=C(O)C=C2C MEKOFIRRDATTAG-UHFFFAOYSA-N 0.000 claims description 6
- 230000000850 deacetylating effect Effects 0.000 claims description 2
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 claims 12
- 239000002904 solvent Substances 0.000 abstract description 10
- HOPRXXXSABQWAV-UHFFFAOYSA-N anhydrous collidine Natural products CC1=CC=NC(C)=C1C HOPRXXXSABQWAV-UHFFFAOYSA-N 0.000 abstract description 3
- WQDUMFSSJAZKTM-UHFFFAOYSA-N Sodium methoxide Chemical compound [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 abstract description 2
- FTVLMFQEYACZNP-UHFFFAOYSA-N trimethylsilyl trifluoromethanesulfonate Chemical compound C[Si](C)(C)OS(=O)(=O)C(F)(F)F FTVLMFQEYACZNP-UHFFFAOYSA-N 0.000 abstract description 2
- 125000000218 acetic acid group Chemical group C(C)(=O)* 0.000 abstract 1
- 239000007795 chemical reaction product Substances 0.000 abstract 1
- 238000006243 chemical reaction Methods 0.000 description 11
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 9
- WSLDOOZREJYCGB-UHFFFAOYSA-N 1,2-Dichloroethane Chemical compound ClCCCl WSLDOOZREJYCGB-UHFFFAOYSA-N 0.000 description 8
- 238000005481 NMR spectroscopy Methods 0.000 description 6
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 6
- 238000000921 elemental analysis Methods 0.000 description 6
- 230000003287 optical effect Effects 0.000 description 5
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 4
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 238000001644 13C nuclear magnetic resonance spectroscopy Methods 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- 239000003480 eluent Substances 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 238000002844 melting Methods 0.000 description 3
- 230000008018 melting Effects 0.000 description 3
- 229910052757 nitrogen Inorganic materials 0.000 description 3
- 239000012044 organic layer Substances 0.000 description 3
- 239000000741 silica gel Substances 0.000 description 3
- 229910002027 silica gel Inorganic materials 0.000 description 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 239000013543 active substance Substances 0.000 description 2
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 2
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 2
- 239000012141 concentrate Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 2
- 235000019341 magnesium sulphate Nutrition 0.000 description 2
- OVARTBFNCCXQKS-UHFFFAOYSA-N propan-2-one;hydrate Chemical compound O.CC(C)=O OVARTBFNCCXQKS-UHFFFAOYSA-N 0.000 description 2
- 235000017557 sodium bicarbonate Nutrition 0.000 description 2
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- QIVUCLWGARAQIO-OLIXTKCUSA-N (3s)-n-[(3s,5s,6r)-6-methyl-2-oxo-1-(2,2,2-trifluoroethyl)-5-(2,3,6-trifluorophenyl)piperidin-3-yl]-2-oxospiro[1h-pyrrolo[2,3-b]pyridine-3,6'-5,7-dihydrocyclopenta[b]pyridine]-3'-carboxamide Chemical compound C1([C@H]2[C@H](N(C(=O)[C@@H](NC(=O)C=3C=C4C[C@]5(CC4=NC=3)C3=CC=CN=C3NC5=O)C2)CC(F)(F)F)C)=C(F)C=CC(F)=C1F QIVUCLWGARAQIO-OLIXTKCUSA-N 0.000 description 1
- 241000218033 Hibiscus Species 0.000 description 1
- 235000005206 Hibiscus Nutrition 0.000 description 1
- 235000007185 Hibiscus lunariifolius Nutrition 0.000 description 1
- 229920005654 Sephadex Polymers 0.000 description 1
- 239000012507 Sephadex™ Substances 0.000 description 1
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 1
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 1
- HDTRYLNUVZCQOY-NCFXGAEVSA-N beta,beta-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-NCFXGAEVSA-N 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 229920001429 chelating resin Polymers 0.000 description 1
- 229940125904 compound 1 Drugs 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- SRCZQMGIVIYBBJ-UHFFFAOYSA-N ethoxyethane;ethyl acetate Chemical compound CCOCC.CCOC(C)=O SRCZQMGIVIYBBJ-UHFFFAOYSA-N 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 238000002523 gelfiltration Methods 0.000 description 1
- GRWIABMEEKERFV-UHFFFAOYSA-N methanol;oxolane Chemical compound OC.C1CCOC1 GRWIABMEEKERFV-UHFFFAOYSA-N 0.000 description 1
- 239000012046 mixed solvent Substances 0.000 description 1
- XULSCZPZVQIMFM-IPZQJPLYSA-N odevixibat Chemical compound C12=CC(SC)=C(OCC(=O)N[C@@H](C(=O)N[C@@H](CC)C(O)=O)C=3C=CC(O)=CC=3)C=C2S(=O)(=O)NC(CCCC)(CCCC)CN1C1=CC=CC=C1 XULSCZPZVQIMFM-IPZQJPLYSA-N 0.000 description 1
- 150000002905 orthoesters Chemical class 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000006462 rearrangement reaction Methods 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- WYURNTSHIVDZCO-UHFFFAOYSA-N tetrahydrofuran Substances C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Landscapes
- Saccharide Compounds (AREA)
Abstract
Description
【発明の詳細な説明】
(産業上の利用分野)
本発明は、トレハロースの異性体であるイソトレハロー
ス又はネオトレハロースの製造方法に関する。DETAILED DESCRIPTION OF THE INVENTION (Industrial Application Field) The present invention relates to a method for producing isotrehalose or neotrehalose, which is an isomer of trehalose.
(従来の技術)
α、α−1・レバロースは、コードファクターと呼称さ
れるトレハロースのミコール酸エステルの糖骨格として
、また、その他生理活性物質の糖質原料として重要な物
質である。(Prior Art) α, α-1 levalose is an important substance as a sugar skeleton of mycolic acid ester of trehalose called code factor and as a carbohydrate raw material for other physiologically active substances.
生理活性物質の構造と活性の相関を調べるためには、糖
骨格をイソトレハロース(β、β−トレハロース)もし
くはネオトレハロース(α、βl・レバロース)に変換
する必要がある。In order to investigate the relationship between the structure and activity of physiologically active substances, it is necessary to convert the sugar skeleton into isotrehalose (β, β-trehalose) or neotrehalose (α, βl-levalose).
古くは、イソトレハロースの製造方法として、ft、)
1.Scl+1ubachらの方法[Z、PI+ysi
o1.Chem、、213(1932) 83 ]があ
り、ネオトレハロースの製造方法としては、胃、N、H
aworthらの方法しジャーナル・オブ・ケミカル・
ソサエティー(Jou+・nal orChemica
l 5ociety ) 、 (1931) 2B47
]が知られている。In ancient times, as a method for producing isotrehalose, ft,)
1. Scl+lubach et al.'s method [Z, PI+ysi
o1. Chem, 213 (1932) 83], and methods for producing neotrehalose include stomach, N, H
The method of Aworth et al., Journal of Chemical
Society (Jou+・nal or Chemica
(1931) 2B47
]It has been known.
それらの方法は、下記のような方法である。Those methods are as follows.
H,11,5chlubachらの方法(1932年)
イソトレハロース
(以下余白)
〜す、N、IIawnrt、h らの方法 (1931
年)■
ネオ1・レバロース
最近のイソトレハロースの製造方法としては、S、J、
Cookらの方法[ジャーナル・オブ・カーホハイドレ
−1−・ケミストリー(J、CarbohydraLe
Cbemistry) 、 L (1984) 343
]があり、ネネオ・レバロースの製造方法としては、
J、Yosl+ imuraらの方法[ケミストリー・
レターズ(Chemistry LeLL−ers)
、 (1983) 319]が報告されている。H, 11,5 Chlubach et al.'s method (1932)
Isotrehalose (hereinafter referred to as margin) Method of ~S, N, IIawnrt, h et al. (1931
) ■ Neo 1 Levalose Recent methods of producing isotrehalose include S, J,
The method of Cook et al. [Journal of Carbohydra-1-Chemistry
Cbemistry), L (1984) 343
], and the manufacturing method of Neneo Lebarose is as follows.
J, Yosl+ Imura et al.'s method [Chemistry
Letters (Chemistry LeLL-ers)
, (1983) 319] has been reported.
それらの方法は、下記のような方法である。Those methods are as follows.
S、J、Cookらの方法(1984年)= 10
J 、 Y (l S II i m u r a ら
の方法 (1983年)(式中、Bnはベンジル基を示
す)
(発明が解決しようとする課題)
しかしながら、従来のイソトレハロース又はネオトレハ
ロースのpJ 3P+方法は、イソトレハロース誘導体
とネオ1へレバロース誘導体とを同時に製造することが
てきず、とちらか−力を製)ムした(多他を得ようとし
ても、その−・方の製造中間体から他方を有利に得る方
法が無く、最初から他方を製造する以外に方法がなかっ
たのである。S, J. Cook et al.'s method (1984) = 10 J, Y (l S II i m ura et al.'s method (1983) (wherein, Bn represents a benzyl group) (In the formula, Bn represents a benzyl group) However, the conventional pJ3P+ method for isotrehalose or neotrehalose is unable to simultaneously produce isotrehalose derivatives and neo1 helevalose derivatives, resulting in a large number of problems. Even if one tried to obtain the other, there was no way to advantageously obtain the other from the production intermediate of the one, and there was no other way than to produce the other from the beginning.
従って、イソ1〜レバロース誘導体とネオ1・レバロー
ス誘導体とを同時に製造でき、簡素な操作でイソトレハ
ロース又はネオトレハロースを個別に製造出来る方法の
開発が望まれていた。Therefore, it has been desired to develop a method that can simultaneously produce iso-1-levalose derivatives and neo-1-levalose derivatives, and can produce isotrehalose or neotrehalose individually with simple operations.
(課題を解決するための手段)
本発明者等は、」1記課題を解決するために鋭意研究を
重ねた結果、オルソエステルの分子内転位を経由するこ
とにより、イソトレハロース誘導体とネオトレハロース
誘導体とを同時に製造ケることに成功し、更に、簡素な
操作でイソトレハロース又はネオ1へレバロースを個別
に得ることに成功し、また、イソトレハロース及びネオ
トレハロースの混合物を製造することにも成功し、本発
明を完成するに至った。(Means for Solving the Problems) As a result of intensive research to solve the problem described in item 1, the present inventors have discovered that isotrehalose derivatives and neotrehalose derivatives can be produced by intramolecular rearrangement of orthoesters. Furthermore, they succeeded in producing isotrehalose or neo-1 helevalose individually with simple operations, and also succeeded in producing a mixture of isotrehalose and neotrehalose. , we have completed the present invention.
以下に本発明の内容を詳細に説明する。The contents of the present invention will be explained in detail below.
化合物(3)及び化合物(4)は、後]ホのスA−1\
1に示すように、公知化合物の1ヒ合1勿(13「K;
げjala & Link、ジャーナル・オブ・アメリ
カン ケミカル・ソサエティー(J、八m、chem、
soc、 ) 、6二2−(1940) 917の方法
により製う覧することができる。]と化合e+ (2>
[C,M、McCloskeyら、ジャーナル・オ
ブ・アメリカン・ケミカル・ソサエティー(、IAm、
Chem、Soc、)、四−(1944) 349の方
法により製造することができる。コとから合成すること
がてきる。Compound (3) and compound (4) are the following: A-1\
As shown in 1, one combination of known compounds (13 "K;
Gejala & Link, Journal of American Chemical Society (J, 8m, chem,
soc, ), 622-(1940) 917. ] and the compound e+ (2>
[C, M, McCloskey et al., Journal of the American Chemical Society (, IAm,
Chem, Soc.), 4-(1944) 349. It can be synthesized from
この合成反応は、例えば、1.2−ジクロロエタンのよ
うなン容媒中、銀1へリフレート(八gO802CF3
)、更にはS−コリジンの存在下て、実施することが好
ましい。This synthetic reaction is performed, for example, by reflating (8gO802CF3) to silver 1 in a medium such as 1,2-dichloroethane.
), and more preferably in the presence of S-collidine.
また、この合成反応は、N2等の雰囲気下、50〜50
℃の温度て、1分〜24時間、反応系を攪拌しながら行
うことが望ましい。In addition, this synthesis reaction is carried out under an atmosphere such as N2 at 50 to 50
It is preferable to carry out the reaction at a temperature of 1 minute to 24 hours while stirring the reaction system.
更に、この合成反応は、1,2−ジクロロエタン中、ト
リエチルアミンの存在下、還流する刑法によっても実施
することができる。Furthermore, this synthetic reaction can also be carried out by refluxing in 1,2-dichloroethane in the presence of triethylamine.
イソトレハロース誘導体である化合物(5)及び考・オ
ドレバロース誘導体であるfじ音1句(6)は1ヒ音物
(3)もしくは化合物(4)の分子内転位により合成す
ることができる。Compound (5), which is an isotrehalose derivative, and f-jion 1-phrase (6), which is an odorevalose derivative, can be synthesized by intramolecular rearrangement of 1-hyphen (3) or compound (4).
この分子内転位は、例えば、1.2−ジクロエタンのよ
うな溶媒中、トリメチルシリルトリフルオロメタンスル
ホネート
することがある。)の存在下で、実施することが好まし
い。This intramolecular rearrangement may occur, for example, to trimethylsilyltrifluoromethanesulfonate in a solvent such as 1,2-dichloroethane. ) is preferably carried out.
また、この転位反応は、−50〜50℃の温度で、1分
〜24時間、反応系を攪拌しながら行うことが好ましい
。Further, this rearrangement reaction is preferably carried out at a temperature of -50 to 50°C for 1 minute to 24 hours while stirring the reaction system.
イソトレハロース(7)は、化合物(5)を脱アセデル
化することによってき成することができる。Isotrehalose (7) can be synthesized by deacetylation of compound (5).
この脱アセチル化は、例えば、メタノール−テトラヒド
ロフラン(以下、THFと略することがある。)系の溶
媒中、NaOCH3で処理することによって実施するこ
とが好ましい。This deacetylation is preferably carried out, for example, by treatment with NaOCH3 in a methanol-tetrahydrofuran (hereinafter sometimes abbreviated as THF) solvent.
また、ネオ1・レバロース(8)は、化合1勿(6)を
脱アセチル化することによって合成することができる。Furthermore, neo-1 levalose (8) can be synthesized by deacetylating compound 1-revalose (6).
この脱アセデル化は、メタノール等の溶媒中、N a
O C. H 3で処理することによって実施するこ]
3
とが女子ましい。This deacetylation is carried out in a solvent such as methanol with N a
OC. This can be carried out by processing with H3]
3 It's feminine.
また、必要に応して、イソトレハロース誘導体及びネオ
トレハロース誘導体σ)混合物からイソトレハロース及
びネオ1・レバロースを同時に製造するにとがてきる。Moreover, if necessary, isotrehalose and neo-1.levalose can be simultaneously produced from the isotrehalose derivative and neotrehalose derivative σ) mixture.
尚、前記工程において合成される化合1勿(3)及び化
合物(4)は新規化合物である。Note that Compound 1 (3) and Compound (4) synthesized in the above steps are new compounds.
(以下余白)
(実施例)
以下に実施例を挙げて本発明の内容を更に具体的に説明
するが、本発明の範囲は以下の実施例に限定されるもの
ではない。(The following is a blank space) (Example) The content of the present invention will be described in more detail with reference to Examples below, but the scope of the present invention is not limited to the following Examples.
実施例−1[化合物(1) +(2)→(3) +(4
) ]10.3gのAg08O2CF3に100 mA
の1.2−ジクロロエタンを加え、・系内を窒素置換し
た。次に、110m(!の1.2−ジクロロエタンに溶
解した化合物(2) 11.0g (31,6mモル)
とS−コリジン5.3m(40,1mモル)を加えて、
0°Cまで冷却した。Example-1 [Compound (1) + (2) → (3) + (4
)] 100 mA for 10.3 g of Ag08O2CF3
1,2-dichloroethane was added, and the system was purged with nitrogen. Next, 11.0 g (31.6 mmol) of compound (2) dissolved in 1,2-dichloroethane of 110 m(!)
and 5.3 m (40.1 mmol) of S-collidine were added,
Cooled to 0°C.
そして、150aQの1,2−ジクロロエタンに溶解し
た化音物(1) 15.0g (36,5mfル)を滴
下しながら加えた。Then, 15.0 g (36.5 mf) of the compound (1) dissolved in 150 aQ of 1,2-dichloroethane was added dropwise.
反応は0℃→室温で19時間行っな。反応終了後、1ρ
のCll2Cρ2を加えてセライト濾過し、塩酸処理、
重曹処理、水洗をして、有機層をMgSO4で乾燥した
。The reaction was carried out at 0°C → room temperature for 19 hours. After the reaction, 1ρ
of Cll2Cρ2 was added, filtered through Celite, treated with hydrochloric acid,
After treatment with sodium bicarbonate and washing with water, the organic layer was dried with MgSO4.
濾過後、減圧濃縮して、その残渣をシリカゲル1.8k
gのカラム(溶出剤:クロ亀コポルムーア七トン=20
:1.)に通して分離精製し、化合物(3)を7.0g
(収率32,7%)、化合物(4)を10.0g(収率
46,7%)得た。After filtration, concentrate under reduced pressure and transfer the residue to 1.8k silica gel.
g column (eluent: Kurokame Kopormoor 7 tons = 20
:1. ) to separate and purify 7.0g of compound (3).
(yield 32.7%), and 10.0 g (yield 46.7%) of compound (4) were obtained.
[化合物(3)の性質]
′rLCRf=0.34 (り00ポルムアセトン=1
0:1)
元素分析 (C2sH380+9として)泪算値 C、
49,56・ I−15,64測定値 C、49,68
; H、5,64比旋光度 [α]o+17.7゜
(C3,01,Cl−IC,Q3)
111−NMR(CDCj 、 )
5.692(cl、Ill、J5.3711z、ll−
1a)4.775(d、Ill、J8.0611z、l
t−1b)。[Properties of compound (3)] 'rLCRf=0.34 (Li00pormacetone=1
0:1) Elemental analysis (as C2sH380+9) Calculated value C,
49,56・I-15,64 measurement value C, 49,68
; H, 5,64 specific optical rotation [α]o+17.7° (C3,01, Cl-IC, Q3) 111-NMR (CDCj, ) 5.692 (cl, Ill, J5.3711z, ll-
1a) 4.775 (d, Ill, J8.0611z, l
t-1b).
2.100(s、311.八c)、2.094(s、6
11.2AC)1”、C−NMR(CIICj3)
97.1(’Jc++181.911..C−1a)。2.100 (s, 311.8c), 2.094 (s, 6
11.2AC)1'', C-NMR (CIICj3) 97.1 ('Jc++181.911..C-1a).
94.6(’Jco161.I11..C−1b)。94.6 ('Jco161.I11..C-1b).
[化合物(4)の性質]
TLCr?、f=0.41 (クロロポルノ、アセ1−
ン−10・1)
元素分析 (C281−138019として)計算値
C,49,56,1−1,5,64測定値 c 、 4
9.26・ 11 5.59比旋光度 [α]o+73
.7゜
(C3,01、Cl−IC,Q3 )
IN−N14R(CDCj、)
5.785(d、ILI、、J5.3711z、H−1
a>。[Properties of compound (4)] TLCr? , f=0.41 (chloroporno, ace1-
-10・1) Elemental analysis (as C281-138019) Calculated value
C, 49, 56, 1-1, 5, 64 measurement value c, 4
9.26・ 11 5.59 Specific optical rotation [α]o+73
.. 7゜(C3,01, Cl-IC, Q3) IN-N14R(CDCj,) 5.785(d, ILI,, J5.3711z, H-1
a>.
5.307((+、 Ill、、13.91tlz、l
l−1b)2.114(s、311.Ac)、2.09
9(s、6+I、2AC)2.079(s、31+、A
c)、2.033(s、6tl、2Ac)。5.307((+, Ill,, 13.91tlz, l
l-1b) 2.114 (s, 311.Ac), 2.09
9(s, 6+I, 2AC) 2.079(s, 31+, A
c), 2.033 (s, 6tl, 2Ac).
2.003(s、31(、八〇)。2.003(s, 31(, 80).
0.
1、.753(s、3H,O;C−Cl13)”C−N
MR(CDCj3)
97.3(’、Icu183.ill、、C−1a)。0. 1. 753(s, 3H, O; C-Cl13)"C-N
MR (CDCj3) 97.3 (', Icu183.ill,, C-1a).
90.5(’Jco172.IH2,C−1b)実施例
−2[化合物(3)−化合物(s) +(0) ]化合
物(3)1.8.6gを1.2−ジクロロエタン300
mQに溶解し、0°Cまで冷却して、TMSOTf5
.3 m、Qを加え、1時間攪拌した。反応終了後、C
l2Cρ21、Qを加え、重曹処理後、有機層をMg5
o4で乾燥した。90.5 ('Jco172.IH2, C-1b) Example-2 [Compound (3) - Compound (s) + (0)] 1.8.6 g of compound (3) was added to 300 g of 1.2-dichloroethane
TMSOTf5 was dissolved in mQ and cooled to 0 °C.
.. 3 m and Q were added and stirred for 1 hour. After the reaction is complete, C
l2Cρ21, Q was added, and after baking soda treatment, the organic layer was mixed with Mg5
Dry with O4.
濾過後、減−圧潰線して、残渣をシリカゲル1゜8kg
のカラム(溶出剤:クロロポルムーアセトン=10:1
)に通して分離精製し、酢酸エチルエーテル系溶媒で結
晶化して、化合物(5)を7.21g(収率38.8%
)、1ヒ自物(6)を0.47g (収率2.5%)得
た。After filtration, reduce and crush the residue to 1°8 kg of silica gel.
column (eluent: chloropormoacetone = 10:1
) and crystallized with ethyl acetate solvent to obtain 7.21 g of compound (5) (yield 38.8%).
), 0.47 g (yield 2.5%) of 1 Hibiscus (6) was obtained.
[化合物(5)の性質1
TLCR,f=0.33(クロロボルムアセトン−10
: ]、 )
元素分析 (C2s038019として)計算値 C、
49,’)6; tl 、 5.64測定値 C、4
9,26・ [(5,59比旋光度 [α]。−11,
1゜
(C1,75,Cト1c、(7<)
[文献値−15,5°、前記S、、J、Cookらの文
献(C5,4,CHCff13) ]
融点 178〜180℃
「文献値1.81.5〜183°C1文献は同」−]’
l−NMR(CDCj3)
4.902(d、J7.33)Iz、H−1,H−1’
)2.106,2.062,2.027,2.009(
4s、4AcX 2)「文献値4.9(d、、J811
z、Iト1 、Illo)1文献は同」二]”C−N1
dR(CIICJJ
96.6(C−1,C−1>
[化合物(6)の性質]
TLCR,f=0.35 (りl′’? +:’?ポル
ムアセトンー10:1)
元素分析 (C2883FIO+9として)31算値
C,49,56,H,5,64測定値 C,49,58
: tl、 5.65比旋光度 [α]o +74
.O。[Property 1 of compound (5) TLCR, f = 0.33 (chloroboramacetone-10
: ], ) Elemental analysis (as C2s038019) Calculated value C,
49,')6; tl, 5.64 measured value C, 4
9,26・[(5,59Specific optical rotation [α].-11,
1° (C1,75, Cto1c, (7<) [Literature value -15,5°, the literature of S, J, Cook et al. (C5,4, CHCff13)] Melting point 178-180°C "Literature value 1.81.5~183°C1 The literature is the same"-]'
l-NMR (CDCj3) 4.902 (d, J7.33) Iz, H-1, H-1'
) 2.106, 2.062, 2.027, 2.009 (
4s, 4AcX 2) "Literature value 4.9 (d,, J811
z, Ito1, Illo)1 References are the same"2]"C-N1
dR (CIICJJ 96.6 (C-1, C-1> [Properties of compound (6)] TLCR, f = 0.35 (Rl''? +:'? Polacetone - 10:1) Elemental analysis (as C2883FIO+9 )31 calculation value
C, 49, 56, H, 5, 64 measurement value C, 49, 58
: tl, 5.65 specific optical rotation [α]o +74
.. O.
(C1,,00,Cl−IC,Q3)
「文献値+82°(c5 、 ClIC夕、)、前記V
1.N、IIawnrLhらの文献]
融点 1385〜1,40.5°C[文献値14
0〜141℃、文献は同上コ’It−NMR(CDCj
、、、)
5.348(d、1.11.J3.6611z、a−1
1−1,)4.704(d、ltl、、JR,0611
z、β−8−1>2.119,2.092,2.040
. (3s、911,3Ac)2.038(s、611
2AC>、2.027(S、3+1.八()2.01
4(s、6H,2AC)
”C−NMR(CDCj3)
100.0(’Jcu16]、、1)1z、β−C−1
)96.9(’JCI+175.8117. a−C−
] )実施例−3[化合物(4)→化合物(5) +(
6) ]化合物(4)10.04gを1,2−ジクロロ
エタン180mρに溶解し、0°Cまて冷却して、1°
MS OT f 2 、9 mQを加え、1時間攪拌し
た。(C1, 00, Cl-IC, Q3) "Literature value +82° (c5, ClIC evening,), the above V
1. N, IIawnrLh et al.] Melting point 1385-1,40.5°C [Literature value 14
0 to 141°C, the literature is the same as above.It-NMR (CDCj
,,,) 5.348(d, 1.11.J3.6611z, a-1
1-1,)4.704(d,ltl,,JR,0611
z, β-8-1>2.119, 2.092, 2.040
.. (3s, 911, 3Ac) 2.038 (s, 611
2AC>, 2.027(S, 3+1.8()2.01
4(s, 6H, 2AC) "C-NMR (CDCj3) 100.0 ('Jcu16],, 1) 1z, β-C-1
)96.9('JCI+175.8117.a-C-
) Example-3 [Compound (4) → Compound (5) +(
6)] 10.04 g of compound (4) was dissolved in 180 mρ of 1,2-dichloroethane, cooled to 0°C, and heated to 1°C.
MS OT f 2 , 9 mQ was added and stirred for 1 hour.
反応終了後、CH2C424,OOmQを加え、重曹処
理後、有機層をMgSO4で乾燥した。After the reaction was completed, CH2C424 and OOmQ were added, and after treatment with sodium bicarbonate, the organic layer was dried with MgSO4.
濾過後、減圧濃縮して、残渣をシリカゲル16 k g
のカラム(溶出剤:クロロポルム−アセI・ンー]、
O: 1 )に通して分離・精製し、酢酸エチルーエー
テル系溶媒て結晶化して、化合物(5)をo、62g(
収率6.2%)、化合物(6)を074g(収率7.4
%)得な。After filtration, concentrate under reduced pressure and transfer the residue to 16 kg of silica gel.
column (eluent: chloroporum-acetate),
O: 1) to separate and purify the compound (5), and crystallize from an ethyl acetate-ether solvent to obtain compound (5), 62 g (
074g of compound (6) (yield 7.4%)
%) Good value.
実施例−4[化合物(5) =(7) ]化合物(5)
4.03gをメタノール250 tnQとTHF15m
Qの混合溶媒に溶解し、lN−Na0CH,1mΩを加
えて、室温で19時間攪拌した。Example-4 [Compound (5) = (7)] Compound (5)
4.03g methanol 250tnQ and THF15m
Q was dissolved in a mixed solvent, 1N-Na0CH, 1 mΩ was added thereto, and the mixture was stirred at room temperature for 19 hours.
反応終了後、アンバーライト(Amber l ite
) IR,C−50(ローム・アンド・ハース社製)
をOmQ加え、20分間攪拌して中和し、セライト濾過
後、減圧濃縮した。After the reaction is completed, amber light (Amber light)
) IR, C-50 (manufactured by Rohm and Haas)
was added to OmQ, stirred for 20 minutes to neutralize, filtered through Celite, and concentrated under reduced pressure.
残渣をゲル濾過[セファデックス(5ephadex)
G−25(ファルマシア社製) 30 OmQ、 H2
0]により、精製し、水−アセトン系溶媒で結晶化して
、化合物(7)を1..87g得た(収率920%)。Gel filtration of the residue [Sephadex (5ephadex)]
G-25 (manufactured by Pharmacia) 30 OmQ, H2
Compound (7) was purified by 1.0] and crystallized from a water-acetone solvent. .. 87g was obtained (yield 920%).
[化合物(7)の性質]
TLCRf=0.26(酢酸エチルー工り5ノール−水
−8:4:2>
元素分析 (C+2022011・I/2l−12(つ
として)計算値 C,41,02: H、(1,6(
1測定値 C、40,83; )(、6,59比旋光
度 [αID−4,1,4゜
(C]、 、 01 、 H20)[文献値−39
6(C7,4,+420)、前記S、J、Cookらの
文献]
融点 1.30.5へ−1,37、0’c[文献
値134〜139°C5文献は同」−]’II−NMR
(D20.50℃)
4.817(d、J8.0611z、It−]−、H−
]’ )[文献値(24℃) 4.74(d、J7.5
11z、Ill 、Ill゛)、文献は同上]
”C−NMR(D20)
100.0(’、Jco162.3Hz、C−]、 、
C−1’ )実施例−5[化合物(6)→(8)]
化合物(6)1..38gをメタノール28 mQに溶
解し、I N−Na0CH3o、4mQを加えて、室温
で18時間攪拌した。[Properties of compound (7)] TLCRf=0.26 (ethyl acetate-5-nol-water-8:4:2> Elemental analysis (C+2022011・I/2l-12 (as one) calculated value C, 41,02 : H, (1,6(
1 Measured value C, 40,83;
6 (C7,4, +420), the above-mentioned literature of S, J, Cook et al.] Melting point 1.30.5 to -1,37,0'c [Literature value 134-139°C5 literature is the same"-]'II -NMR
(D20.50°C) 4.817(d, J8.0611z, It-]-, H-
) [Literature value (24℃) 4.74 (d, J7.5
11z, Ill, Ill゛), literature is same as above] "C-NMR (D20) 100.0 (', Jco162.3Hz, C-],
C-1') Example-5 [Compound (6)→(8)] Compound (6)1. .. 38 g was dissolved in 28 mQ of methanol, 4 mQ of IN-Na0CH3o was added, and the mixture was stirred at room temperature for 18 hours.
反応終了後、アンバーライト(AmberliLe )
JRC−50を2.4nt9加え、20分間攪拌して
中和し、セライト濾過後、減圧濃縮した。After the reaction is completed, Amberlite (AmberliLe)
2.4 nt9 of JRC-50 was added, stirred for 20 minutes to neutralize, filtered through Celite, and concentrated under reduced pressure.
残渣を水4 mQに溶解し、活性炭処理をして、減圧濃
縮した。The residue was dissolved in 4 mQ of water, treated with activated carbon, and concentrated under reduced pressure.
その残渣を水−アセトン系溶媒で結晶化して、化合物(
8)を436.3mg得た(収率62.7%)。The residue was crystallized from a water-acetone solvent to obtain the compound (
8) was obtained in an amount of 436.3 mg (yield: 62.7%).
[化合物(8)の性質]
TLCR,f=0.16(i’it:酸エチルーエタノ
ールー水−8:4:2)
元素分析 (C+□H220,、・1120とし−て)
計算値 C、40,00; H、6,71測定値 C
、40,04; H、6,68比旋光度 [α]o+
84.8゜
(C1,00,H20)
[文献値+95°(C3,55,1120) 、前記W
、N、11.1w o r t hらの文献1
+11−NMR(I)20,50℃)
5.244(d、1N、+3.66Hz、σ−II −
]、 )4.655(d、Ill、、+7.8211z
、β−ト1)+ 3C−NMR(D20)
103.8(’Jcn161.111z、β−C−1)
101.1(’Jco170.9Hz、a−C−1>(
発明の効果)
本発明を実施することにより、イソトレハロース誘導体
とネオトレハロース誘導体とを同時に製造することがで
き、簡素な操作により、イソトレハロース又はネオトレ
ハロースを個別に製造することができる。[Properties of compound (8)] TLCR, f=0.16 (i'it: acid ethyl-ethanol-water-8:4:2) Elemental analysis (as C+□H220,,・1120)
Calculated value C, 40,00; H, 6,71 Measured value C
, 40,04; H, 6,68 specific optical rotation [α]o+
84.8° (C1,00, H20) [Literature value +95° (C3,55,1120), above W
, N, 11.1w or th et al. 1 +11-NMR (I) 20,50°C) 5.244 (d, 1N, +3.66Hz, σ-II -
], )4.655(d,Ill,,+7.8211z
, β-t1) + 3C-NMR (D20) 103.8 ('Jcn161.111z, β-C-1)
101.1('Jco170.9Hz, a-C-1>(
Effects of the Invention) By carrying out the present invention, isotrehalose derivatives and neotrehalose derivatives can be produced simultaneously, and isotrehalose or neotrehalose can be produced individually by simple operations.
特許出願人 東和化成]二業株式会社Patent applicant: Towa Kasei] Nigyo Co., Ltd.
Claims (1)
(1)と、 次式(II)、 ▲数式、化学式、表等があります▼(II) (式中、Acはアセチル基を示す。)で示される化合物
(2)とを反応させて、 次式(III)、 ▲数式、化学式、表等があります▼(III) (式中、Acはアセチル基を示す。)で示される化合物
(3)と、 次式(IV)、 ▲数式、化学式、表等があります▼(IV) (式中、Acはアセチル基を示す。)で示される化合物
(4)とを製造する工程、 (b)化合物(3)及び/又は化合物(4)の分子内転
位により、次式(V)、 ▲数式、化学式、表等があります▼(V) (式中、Acはアセチル基を示す。)で示される化合物
(5)と、 次式(VI)、 ▲数式、化学式、表等があります▼(VI) (式中、Acはアセチル基を示す。)で示される化合物
(6)とを製造する工程、 (c)化合物(5)を脱アセチル化し、イソトレハの諸
工程からなることを特徴とするトレハロース異性体の製
造方法。 2 (a)次式( I )、 ▲数式、化学式、表等があります▼( I ) (式中、Acはアセチル基を示す。)で示される化合物
(1)と、 次式(II)、 ▲数式、化学式、表等があります▼(II) (式中、Acはアセチル基を示す。)で示される化合物
(2)とを反応させて、 次式(III)、 ▲数式、化学式、表等があります▼(III) (式中、Acはアセチル基を示す。)で示される化合物
(3)と、 次式(IV)、 ▲数式、化学式、表等があります▼(IV) (式中、Acはアセチル基を示す。)で示される化合物
(4)とを製造する工程、 (b)化合物(3)及び/又は化合物(4)の分子内転
移により、次式(V)、 ▲数式、化学式、表等があります▼(V) (式中、Acはアセチル基を示す。)で示される化合物
(5)と、 次式(VI)、 ▲数式、化学式、表等があります▼(VI) (式中、Acはアセチル基を示す。)で示される化合物
(6)とを製造する工程、 (c)化合物(6)を脱アセチル化し、ネオトレハロー
ス[化合物(8)]を製造する工程、 の諸工程からなることを特徴とするトレハロース異性体
の製造方法。[Scope of Claims] 1 (a) A compound (1) represented by the following formula (I), ▲Mathematical formula, chemical formula, table, etc.▼(I) (In the formula, Ac represents an acetyl group); The following formula (II), ▲There are mathematical formulas, chemical formulas, tables, etc.▼(II) (In the formula, Ac represents an acetyl group.) By reacting with the compound (2) shown by the following formula (III), ▲There are mathematical formulas, chemical formulas, tables, etc.▼(III) (In the formula, Ac represents an acetyl group) Compound (3) and the following formula (IV), ▲There are mathematical formulas, chemical formulas, tables, etc.▼ (IV) (In the formula, Ac represents an acetyl group.) Step of producing a compound (4) represented by the following formula, (b) By intramolecular rearrangement of the compound (3) and/or the compound (4), (V), ▲ There are mathematical formulas, chemical formulas, tables, etc. ▼ (V) (In the formula, Ac represents an acetyl group.) Compound (5) shown by the following formula (VI), ▲ Numerical formulas, chemical formulas, tables, etc. ▼(VI) (In the formula, Ac represents an acetyl group.) The process of producing the compound (6) represented by (c) Deacetylation of the compound (5) and isotrehalation process. A method for producing a trehalose isomer, characterized by: 2 (a) Compound (1) represented by the following formula (I), ▲Mathematical formulas, chemical formulas, tables, etc.▼(I) (In the formula, Ac represents an acetyl group), and the following formula (II), ▲There are mathematical formulas, chemical formulas, tables, etc.▼(II) (In the formula, Ac represents an acetyl group.) By reacting with the compound (2), the following formula (III), ▲Mathematical formulas, chemical formulas, tables, etc. ▼ (III) (In the formula, Ac represents an acetyl group.) Compound (3) represented by the following formula (IV), ▲ There are mathematical formulas, chemical formulas, tables, etc. ▼ (IV) (In the formula, , Ac represents an acetyl group) (b) By intramolecular rearrangement of compound (3) and/or compound (4), the following formula (V), ▲ Formula , chemical formulas, tables, etc. ▼ (V) (In the formula, Ac represents an acetyl group) Compound (5) and the following formula (VI), ▲ Numerical formulas, chemical formulas, tables, etc. ▼ (VI ) (In the formula, Ac represents an acetyl group.) (c) A step of deacetylating compound (6) to produce neotrehalose [compound (8)] A method for producing a trehalose isomer, comprising the following steps.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2251946A JP3049565B2 (en) | 1990-09-25 | 1990-09-25 | Method for producing trehalose isomer |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2251946A JP3049565B2 (en) | 1990-09-25 | 1990-09-25 | Method for producing trehalose isomer |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH04134091A true JPH04134091A (en) | 1992-05-07 |
JP3049565B2 JP3049565B2 (en) | 2000-06-05 |
Family
ID=17230334
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2251946A Expired - Fee Related JP3049565B2 (en) | 1990-09-25 | 1990-09-25 | Method for producing trehalose isomer |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP3049565B2 (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1072675C (en) * | 1998-04-24 | 2001-10-10 | 中国科学院生态环境研究中心 | Method for stereospecific synthesis of 1,1 connecting oligose using saccharous ortho-ester as main intermediate material |
CN1072676C (en) * | 1998-07-17 | 2001-10-10 | 中国科学院生态环境研究中心 | Method for synthesizing hexasaccharide and heptasaccharide used as plant immunological system activator using trisaccharid ortho-ester as key intermediate |
CN1072677C (en) * | 1998-07-17 | 2001-10-10 | 中国科学院生态环境研究中心 | Method for synthesizing disaccharide and trisaccharide ortho-esters |
-
1990
- 1990-09-25 JP JP2251946A patent/JP3049565B2/en not_active Expired - Fee Related
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1072675C (en) * | 1998-04-24 | 2001-10-10 | 中国科学院生态环境研究中心 | Method for stereospecific synthesis of 1,1 connecting oligose using saccharous ortho-ester as main intermediate material |
CN1072676C (en) * | 1998-07-17 | 2001-10-10 | 中国科学院生态环境研究中心 | Method for synthesizing hexasaccharide and heptasaccharide used as plant immunological system activator using trisaccharid ortho-ester as key intermediate |
CN1072677C (en) * | 1998-07-17 | 2001-10-10 | 中国科学院生态环境研究中心 | Method for synthesizing disaccharide and trisaccharide ortho-esters |
Also Published As
Publication number | Publication date |
---|---|
JP3049565B2 (en) | 2000-06-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPH0566392B2 (en) | ||
AU707474B2 (en) | Diglycosylated 1,2-diols as mimetics of sialyl-lewis X and sialyl-lewis A | |
JPS61106594A (en) | Manufacture of 2'-deoxyadenosine compound | |
JPS58159499A (en) | Fungicidal 4''-epierythromycin a and derivatives | |
HU181839B (en) | Process for producing diacyl-citosin-arabinosid derivatives | |
EP0270992A2 (en) | Anthracycline derivatives with a cytostatic activity | |
JPH04134091A (en) | Production of trehalose isomer | |
JPH03120292A (en) | Benzopyranone-beta-d-thioxyrocide and method of its preparation | |
EP0080819A1 (en) | 11-0-Alkylerythromycin A derivatives | |
JP2002201192A (en) | New method for synthesizing febrifugine and febrifugine compound | |
AU641644B2 (en) | A process for the preparation of etoposides | |
US3970643A (en) | 5"-Amino-3',5"-dideoxybutirosin A and derivatives | |
CN110028601A (en) | A kind of beta-cyclodextrin derivative, preparation method and the method for preparing supermolecule vesica | |
JPH093088A (en) | Production of aminodisaccharide and chitin or its analogue polysaccharides | |
JPS61282390A (en) | S-neuraminic acid derivative | |
JPH01299294A (en) | 4,8-anhydro-n-acetyleuramic acid derivative | |
DE3837755A1 (en) | 4-DEMETHOXY-ANTHRACYCLINE DERIVATIVES, METHOD FOR THE PRODUCTION AND USE THEREOF | |
CH634581A5 (en) | METHOD FOR PRODUCING A SULFUR TERT. PHOSPHINE GOLD COMPLEX OF A MONO OR DISACCHARID CONTAINING A THIOL GROUP. | |
US4301276A (en) | Synthesis of daunosamine hydrochloride and intermediates used in its preparation | |
US3983102A (en) | Process for preparing 5"-amino-4',5"-dideoxybutirosin A | |
JPH0276892A (en) | 3-phenylthiosialic acid derivative, production thereof, sialic acid-containing oligosugar derivative and production thereof | |
JPH041165A (en) | Novel aceamidoinositols and production thereof | |
JPH03170493A (en) | Plasimycin derivative | |
CN115160399A (en) | Soapbark acid compound and preparation method and medical application thereof | |
JP3542143B2 (en) | Method for producing oligosaccharide |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090331 Year of fee payment: 9 |
|
S531 | Written request for registration of change of domicile |
Free format text: JAPANESE INTERMEDIATE CODE: R313531 |
|
S533 | Written request for registration of change of name |
Free format text: JAPANESE INTERMEDIATE CODE: R313533 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090331 Year of fee payment: 9 |
|
R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
LAPS | Cancellation because of no payment of annual fees |